Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis

BACKGROUND: Nasal hypersecretion due to idiopathic rhinitis can often not be treated sufficiently by conventional medication. Botulinum toxin A (BTA) has been injected into the nasal mucosa in patients with nasal hypersecretion with a reduction of rhinorrhea lasting for about 4 to 8 weeks. Since the...

Descripción completa

Detalles Bibliográficos
Autores principales: Rohrbach, Saskia, Junghans, Katharina, Köhler, Sibylle, Laskawi, Rainer
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770996/
https://www.ncbi.nlm.nih.gov/pubmed/19835591
http://dx.doi.org/10.1186/1746-160X-5-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770996/
https://www.ncbi.nlm.nih.gov/pubmed/19835591
http://dx.doi.org/10.1186/1746-160X-5-18

Ejemplares similares